Prevention of nosocomial infection during nebulization and spirometry;Prévention des infections transmises par la pratique des EFR et l'administration d'aérosols

Revue de Pneumologie Clinique

Volumn 57, Issue 2, 2001, Pages 91-98

  Dautzenberg, B ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Aerosoltherapy; Nebulization; Nosocomial infection; Spirometry

Indexed keywords

BACTERIAL INFECTION; BACTERIUM CONTAMINATION; CLEANING; COST MINIMIZATION ANALYSIS; DISEASE TRANSMISSION; DISINFECTION; FILTER; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE; LEGIONELLA; LUNG FUNCTION TEST; MYCOBACTERIUM; NEBULIZATION; PRION DISEASE; REVIEW; SPIROMETER; SPIROMETRY;

CROSS INFECTION; DISINFECTION; EQUIPMENT CONTAMINATION; HUMANS; INFECTION CONTROL; NEBULIZERS AND VAPORIZERS; PRACTICE GUIDELINES; RESPIRATORY THERAPY; RISK FACTORS; SPIROMETRY;

EID: 6644221640     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Irwin R. S., Demers R. R., Pratter M. R., Garrity F. L., Miner G., Pritchard A., Whitaker S : An outbreak of acinetobacter infection associated with the use of a ventilator spirometer. Respir. Care., 1980, 25, 232-7.
2. Carson L. A., Petersen N. J., Favero M. S., Aguero S. M. : Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl. Environ. Microbiol., 1978, 36, 839-6.
3. Reinarz J. A., Pierce A. K., Mays B. B., Sanford J. P. : The potential role of inhalation therapy equipment in nosocomial pulmonary infection. J. Clin. Invest., 1965, 44, 831-9.
4. Arnow P. M., Chou T., Weil D., Shapiro E. N., Kretzschmar C. : Nosocomial Legionnaires'disease caused by aerosolized tapwater from respiratory devices. J. Infect. Dis., 1982, 146, 460-7.
5. Warachit B. : Nosocomial pneumonia caused by contaminated nebulizer. J. Med. Assoc. Thai., 1988, 71 Suppl 3, 33-4.
6. Edmondson E. B., Sanford J. P. : Simple methods of bacteriologic sampling of nebulization equipment. Am. Rev. Respir. Dis., 1966, 94, 450-3.
7. Gough J., Kraak W. A. G., Anderson E. C., Nichols W. W., Slack M. P. E., McGhie D. : Cross-infection by non-encapsulated Haemophilus influenzae Lancet, 1990, 336, 159-60.
8. Mastro T. D., Fields B. S , Breiman R. F., Campbell J., Plikaytis B. D., Spika J.S. : Nosocomial Legionnaires'disease and use of medication nebulizers. J. Infect Dis., 1991, 163, 667-71.
9. Craven D. E., Lichtenberg D. A., Goularte T. A., Make B. J., McCabe W. R. : Contaminated medication nebulizers in mechanical ventilator circuits. Am. J. Med., 1984, 77, 834-8.
10. ATS Guideline for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention. Respir. Care, 1994, 39, 1191-236.
11. Kendrick A. H., Smith E C., Leeming J. P. : Bacterial colonization as a potential source of nosocomial respiratory infections in spirometers. Eur. Respir J., 1997, 10, 1694-5.
12. Hamill R. J , Houston E. D., Georghiou P. R., Wright C. E., Koza M. A., Cadle R. M., Goepfert P. A., Lewis D. A., Zenon G. J., Clarridge J. E. : An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann. Intern. Med., 1995, 15 ; 122, 762-6.
13. Edmondson E. B., Reinarz J. A., Pierce A. K., Sanford J. P. : Nebulization equipment : a potential source of infection in gram-negative pneumonias. Am. J. Dis. Child, 1966, 111, 357-60.
14. Décret no 95-292 du 16 mars 1995 relatif aux dispositifs médicaux définis à l'article L. 665-3 du code de la santé publique et modifiant ce code (deuxième partie : Décrets en Conseil d'Etat).
15. Conseil Supérieur d'Hygiène Publique de France. Tuberculose : traitement et prévention · Synthèse et recommandations des groupes de travail du Conseil supérieur d'Hygiène publique de France (1995-1996) BEH Numéro spécial 1997.
16. Rosenfeld M., Emerson J., Astley S., Joy P., Williams-Warren J., Standaert T. A., Yim D. L., Crist D., Thykkuttathil M., Torrence M., FitzSimmons S., Ramsey B. : Home nebulizer use among patients with cystic fibrosis. J. Pediatr., 1998, 132, 125-31.
17. Pitchford K. C., Corey M., Highsmith A. K., Perlman R., Bannatyne R., Gold R., Levison H., Ford-Jones E. L. : Pseudomonas species contamination of cystic fibrosis patients'home inhalation equipment. J. Pediatr., 1987, 111, 212-6.
18. Vassal S., Taamma R., Marty N., Sardet A., D'athis P., Bremont F., Dalphin M. L., Plesiat P., Rault G., Thubert J., Dominique S., Lemeland J. F., Derelle J., Blech M. F., Roussey M., Perrin M., Sautegeau A. : Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis. Am. J. Infect. Control, 2000, 28, 347-51.
19. Chaisson R. E., McAvinue S. : Control of tuberculosis during aerosol therapy administration. Respir. Care, 1991, 36, 1017-25.
20. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of tuberculosis in health-care facilities. MMWR, 1994, 43, 1-132.
21. Slosarek M , Kubin M., Pokorny J. : Water as a possible factor of transmission in mycobacterial infections. Cent. Eur. J. Public. Health, 1994, 2, 103-5.
22. Dooley S. W. Jr, Castro K. G., Hutton M. D., Mullan R. J., Polder J. A. Snider D. E. Jr. : Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR, 1990, 39 (RR-17), 1-29.
23. Joseph H., Bates M. D. : FCCP, and Edward Nardell, MD. FCCP. ACCP/ATS Consensus conference institutional control measures for tuberculosis in the era of multiple drug resistance. Chest., 1995, 108, 1690-710.
24. Klein R. S., Motyl M. : Frequency of pulmonary tuberculosis in patients undergoing sputum induction for diagnosis of suspected Pneumocystis carinti pneumonia AIDS, 1993, 7, 1351-5.
25. Chen S. K., Vesley D., Brosseau L. M., Vincent J. H. : Evaluation of single-use masks and respirators for protection of health care workers against mycobacterial aerosols. Am. J. Infect. Control. 1994, 22, 65-74.
26. Circulaire D.G.S/D.H. no100 du 11 décembre 1995 (Creutzfeldt-Jakob) BEH 1996/7.
27. Jakobsson B. M. Onnered A. B., Hjelte L. : Nysrrom Related Articles. Books, LinkOut Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients. J. Hosp. Infect, 1997, 36, 201-7
28. Ahmed J., Brutus A., D'Amato R. F., Glatt A. E. :Acinetobacter calcoaceticus anitratus outbreak in the intensive care unit traced to a peak flow meter. Am. J. Infect. Control, 1994, 22, 319-21.
29. Cox T. R., Roland W. E., Dolan M. E. : Ventilator-related Acinetobacter outbreak in an intensive care unit. Mil. Med., 1998, 163, 389-91.
30. Becquemin M. H., Camus F, Lucet J. C , Denis M., Harzac M., Delprat A., Huchon-Becel D. : Recommandations sur le bienfondé et l'efficacité des filtres en exploration fonctionelle respiratoire. Rev. Mal. Respir., 1999, 16, 585-8.
31. Burgos F., Torres A., Gonzalez J., Puig de la Bellacasa J., Rodriguez-Roisin R., Roca J. : Bacterial colonization as a potential source of nosocomial respiratory infections in two types of spirometer. Eur. Respir J., 1996, 9, 12-7.
32. Hazaleus R. E., Cole J., Berdischewsky M. : Tuberculin skin test conversion from exposure to contaminated pulmonary function testing apparatus. Respir. Care, 1981, 26, 53-5.
33. Recommandations SFAR concernant l'hygiène en anesthésia http : //www.sfar.org/recomhygiene.html.
34. Leemmg J. P., Pryce-Roberts D. M., Kendrick A. H., Smith E. C. : T The efficacy of filters used in respiratory function apparatus. J. Hosp. Infect., 1995, 31, 205-10.
35. Kirk Y. L., Kendall K., Ashworth H. A. : Laboratory evaluation of a filter for the control of cross-infection during pulmonary function testing. J. Hosp. Infect., 1992, 20, 193-8.
36. Side E. A., Harrington G., Thien F., Walters E. H., Johns D. P. : A cost-analysis of two approaches to infection control in a lung function laboratory. Aust. N. Z. J. Med., 1999, 29, 9-14.